Screener
Sarepta Therapeutics, Inc. SRPT Cash Flow Statement
| Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|---|
| -$4.89M-102% | $330.96M+174% | -$282.85M-278% | -$179.95M-635% | $196.89M+2,948% | ||
| $10.41M-4.0% | $10.59M+6.2% | $5.25M-49.8% | $18.45M+88.2% | $10.84M+24.3% | ||
| $24.47M-33.9% | $29.4M-29.0% | $30.02M-39.6% | $14.93M-65.6% | $37.03M-26.7% | ||
| —— | -$202.68M+65.3% | —— | -$14.59M+79.4% | —— | ||
| $555K-98.3% | $2.08M-95.2% | $3.59M-90.6% | $22.93M-38.5% | $31.8M+9.0% | ||
| -$93.37M— | -$134.39M+53.8% | $96.21M-87.4% | —— | —— | ||
| $175M— | $250M— | —— | —— | $0— | ||
| $175M— | $250M— | $35.09M— | $123.33M— | $0— | ||
| —— | $241K-98.1% | -$39.21M-180% | -$117.79M-956% | -$23.82M-160% | ||
| —— | -$336.83M+60.9% | —— | —— | —— |
FAQ
- Where does Sarepta Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Sarepta Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
